737 Innovations at the Product Design and Discovery Interface

Thursday, November 17, 2016: 3:15 PM - 5:45 PM
Continental 5 (Hilton San Francisco Union Square)
Description:
This session focuses on recent advances and innovations at the interface between discovery and product design. Potential topics may include discovery opportunities and novel products with utility in (bio)pharmaceutical, chemical, or biomaterial applications. Submissions from academia and industry are welcome.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Product Design (12G), Pharmaceuticals (15B)

Chair:
William Liechty
Email: WBLiechty@dow.com

Co-Chair:
Mosha H. Zhao
Email: mosha.h.zhao@exxonmobil.com


3:15 PM
(737a) Regulatory Considerations for Introducing New Technologies during Drug Development
Rapti Madurawe

3:36 PM
(737b) Viscoelasticity and Molecular Mobility of Celecoxib/Pvp/Tpgs Melt: A New Approach for Amorphous Drug Dispersion Assessment during Hot Melt Extrusion Product Design
Elba Garcia, Adlin Mendoza, Zuleyka Morales and Darlene Santiago

3:57 PM
(737d) Miniaturized Purification Platform for Automated Screening of Flow Synthesis Using Extraction and Crystallization
Andy Koswara, Edward Barks, Claire Yiqing Liu, Joseph Oliva, Bradley P. Loren, Michael Wleklinski, Zinia Jaman, Ryan T. Hilger, James R. Zimmerman, Conor Parks, David H. Thompson, Robert G. Cooks and Zoltan K. Nagy

4:18 PM
(737e) Novel Validation Method Development for a Drug Delivery Device Used during Breastfeeding
Rebekah Scheuerle, Stephen Gerrard, Krishnaa Mahbubani, Richard Kendall, Sylvaine Bruggraber, Catherine Tuleu and Nigel Slater

4:39 PM
(737f) Photothermal Therapy of Bladder Cancer and Melanoma Via Targeted Single-Walled Carbon Nanotubes
Needa Virani, Patrick McKernan, Barry Lavine, Rajagopal Ramesh, Robert Hurst, Joel Slaton and Roger Harrison

5:00 PM
(737g) Bioproduct Design through Market Assessment: NSF Innovation Corps (I-CorpsTM) Participation Guides the Development of New Escherichia coli Strains
Bob Beitle, Ellen M. Brune, McKinzie Fruchtl and Rudra Palash Mukherjee

5:21 PM
(737h) Recombinant Snake Antivenom Peptide
Claire F. Komives, Michael Balderrama, John Li and Elda E. Sanchez
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>